Literature DB >> 15579747

Long-term follow-up of thyroid function in patients who received bone marrow transplantation during childhood and adolescence.

Hiroyuki Ishiguro1, Yukiharu Yasuda, Yuuichiro Tomita, Tsuyoshi Shinagawa, Takashi Shimizu, Tsuyoshi Morimoto, Kinya Hattori, Masae Matsumoto, Hiroyasu Inoue, Hiromasa Yabe, Miharu Yabe, Osamu Shinohara, Shunichi Kato.   

Abstract

An increasing number of long-term surviving bone marrow transplant (BMT) recipients have recovered from their primary disease but are at risk of developing failure of endocrine organs. We investigated 147 patients who underwent allogeneic BMT. Thyroid function was evaluated by serial measurement of basal TSH and free T4 levels as well as by TRH provocative test. Thyroid ultrasound examination was performed for evaluation of thyroid tumor after BMT. Five patients were found to have overt thyroid dysfunction (hypothyroidism in four patients and hyperthyroidism in one patient). Twenty-three patients in the under 9-yr-old group at BMT and 16 patients in the over 10-yr-old group at BMT had subclinical compensated hypothyroidism. Younger age at BMT was the strongest factor for developing thyroid dysfunction, compared with older age (P < 0.001). Only in patients with subclinical compensated hypothyroidism did median basal and peak TSH increase to the upper half of the normal range by 8 yr after BMT and then returned slightly to the middle of the normal range spontaneously. These results suggest that thyroid dysfunction in long-term BMT survivors depends on age at BMT, with a greater risk among younger patients, indicating the need for life-long surveillance.

Entities:  

Mesh:

Year:  2004        PMID: 15579747     DOI: 10.1210/jc.2004-0836

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  32 in total

1.  Late effects and quality of life of childhood cancer survivors: Part 2. Impact of radiotherapy.

Authors:  Yasushi Ishida; Naoko Sakamoto; Kiyoko Kamibeppu; Naoko Kakee; Tsuyako Iwai; Shuichi Ozono; Naoko Maeda; Jun Okamura; Keiko Asami; Hiroko Inada; Misato Honda; Keizo Horibe
Journal:  Int J Hematol       Date:  2010-06-25       Impact factor: 2.490

2.  NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks.

Authors:  Christopher C Dvorak; Clarisa R Gracia; Jean E Sanders; Edward Y Cheng; K Scott Baker; Michael A Pulsipher; Anna Petryk
Journal:  Biol Blood Marrow Transplant       Date:  2011-10-17       Impact factor: 5.742

Review 3.  The immune system as a regulator of thyroid hormone activity.

Authors:  John R Klein
Journal:  Exp Biol Med (Maywood)       Date:  2006-03

Review 4.  Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up.

Authors:  Smita Bhatia
Journal:  Expert Rev Hematol       Date:  2011-08       Impact factor: 2.929

5.  Endocrine late effects after total body irradiation in patients who received hematopoietic cell transplantation during childhood: a retrospective study from a single institution.

Authors:  Francesco Felicetti; Rosaria Manicone; Andrea Corrias; Chiara Manieri; Eleonora Biasin; Ilaria Bini; Giuseppe Boccuzzi; Enrico Brignardello
Journal:  J Cancer Res Clin Oncol       Date:  2011-07-16       Impact factor: 4.553

6.  Differential effects of radiotherapy on growth and endocrine function among acute leukemia survivors: a childhood cancer survivor study report.

Authors:  Eric J Chow; Wei Liu; Kumar Srivastava; Wendy M Leisenring; Robert J Hayashi; Charles A Sklar; Marilyn Stovall; Leslie L Robison; K Scott Baker
Journal:  Pediatr Blood Cancer       Date:  2012-05-24       Impact factor: 3.167

Review 7.  Subclinical hypothyroidism in childhood - current knowledge and open issues.

Authors:  Mariacarolina Salerno; Donatella Capalbo; Manuela Cerbone; Filippo De Luca
Journal:  Nat Rev Endocrinol       Date:  2016-07-01       Impact factor: 43.330

8.  Autoimmune thyroid disease following alemtuzumab therapy and hematopoietic cell transplantation in pediatric patients with sickle cell disease.

Authors:  Kristen M Williams; Danielle Dietzen; Abeer A Hassoun; Ilene Fennoy; Monica Bhatia
Journal:  Pediatr Blood Cancer       Date:  2014-06-17       Impact factor: 3.167

9.  Prolonged chronic graft-versus-host disease is a risk factor for thyroid failure in long-term survivors after matched sibling donor stem cell transplantation for hematologic malignancies.

Authors:  Bipin N Savani; Eleftheria K Koklanaris; Quan Le; Aarthi Shenoy; Stacey Goodman; A J Barrett
Journal:  Biol Blood Marrow Transplant       Date:  2009-03       Impact factor: 5.742

10.  Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters.

Authors:  D Bresters; A Lawitschka; C Cugno; U Pötschger; A Dalissier; G Michel; K Vettenranta; M Sundin; A Al-Seraihy; M Faraci; P Sedlacek; A B Versluys; A Jenkins; P Lutz; B Gibson; A Leiper; M A Diaz; P J Shaw; R Skinner; T A O'Brien; N Salooja; P Bader; C Peters
Journal:  Bone Marrow Transplant       Date:  2016-06-27       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.